Micromedex NeoFax Reference is no longer on the App Store. It had too few ratings to say what users thought.
Micromedex NeoFax Reference is made and published by
Merative.
AppBrain is an independent app data site and isn't affiliated with Merative.
The app name, icon, screenshots and description belong to Merative and are shown as
published on the App Store.
About Micromedex NeoFax Reference
Micromedex NeoFax Reference was a medical app developed by Merative. It was removed from the App Store Feb 13, 2025.
User Ratings
Micromedex NeoFax Reference was rated 5.00 out of 5 stars, based on one rating ratings.
App Information
Micromedex NeoFax Reference was free. The app size was 6.24 MB. The last available version was 3.0.7. The last update was on February 7, 2025.
Technical Requirements
The app had a content rating of Medium Maturity. The app had been available on the App Store since December 2021.
Description by Merative(from the App Store)
The support of this app will be discontinued on May 20, 2025. Visit the App Store to download the new Micromedex mobile app https://apps.apple.com/app/merative/id6471286555
Micromedex NeoFax Reference app is free to subscribers of Merative Micromedex NeoFax Ref online.
Micromedex NeoFax Reference allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Micromedex NeoFax Reference app is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex for almost 40 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Head of Pediatrics, Director of Pediatrics, Director of the NICU, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to Merative Micromedex® NeoFax® you may obtain free access to this app with your Micromedex NeoFax Reference password. Contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.
